Loading...
Jack Nathan Medical Corp.
JNHMF•PNK
Healthcare
Medical - Care Facilities
$0.004
$0.00(8.11%)
Jack Nathan Medical Corp. (JNHMF) Financial Performance & Income Statement Overview
Review Jack Nathan Medical Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
23.61%
↑ 23.61%
Operating Income Growth
-25.29%
↓ 25.29%
Net Income Growth
6.23%
↑ 6.23%
Operating Cash Flow Growth
-204.67%
↓ 204.67%
Operating Margin
-37.21%
↓ 37.21%
Gross Margin
83.85%
↑ 83.85%
Net Profit Margin
-40.41%
↓ 40.41%
ROE
81.32%
↑ 81.32%
ROIC
-402.30%
↓ 402.30%
Jack Nathan Medical Corp. (JNHMF) Income Statement & Financial Overview
Review Jack Nathan Medical Corp.'s (JNHMF) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $5.25M | $5.39M | $5.28M | $5.41M |
| Cost of Revenue | $962669.00 | $1.15M | $1.14M | $1.46M |
| Gross Profit | $4.29M | $4.24M | $4.14M | $5.10M |
| Gross Profit Ratio | $0.82 | $0.79 | $0.78 | $0.94 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.24M | $5.56M | $5.40M | $7.80M |
| Operating Expenses | $5.57M | $5.92M | $5.75M | $6.56M |
| Total Costs & Expenses | $6.54M | $7.07M | $6.89M | $8.11M |
| Interest Income | $2417.00 | $0.00 | $35959.00 | $61044.00 |
| Interest Expense | $560798.00 | $0.00 | $517143.00 | $622927.00 |
| Depreciation & Amortization | $248891.00 | $331645.00 | $252165.00 | $306014.00 |
| EBITDA | -$1.02M | -$1.40M | -$1.34M | -$2.22M |
| EBITDA Ratio | -$0.19 | -$0.26 | -$0.25 | -$0.41 |
| Operating Income | -$1.29M | -$1.68M | -$1.61M | -$2.70M |
| Operating Income Ratio | -$0.25 | -$0.31 | -$0.31 | -$0.50 |
| Other Income/Expenses (Net) | -$509000.00 | -$644000.00 | -$331000.00 | -$366000.00 |
| Income Before Tax | -$1.80M | -$2.32M | -$1.94M | -$3.06M |
| Income Before Tax Ratio | -$0.34 | -$0.43 | -$0.37 | -$0.57 |
| Income Tax Expense | $124638.00 | $0.00 | $19737.00 | -$806000.00 |
| Net Income | -$1.80M | -$2.32M | -$1.92M | -$2.26M |
| Net Income Ratio | -$0.34 | -$0.43 | -$0.36 | -$0.42 |
| EPS | -$0.02 | -$0.03 | -$0.02 | -$0.03 |
| Diluted EPS | -$0.02 | -$0.03 | -$0.02 | -$0.03 |
| Weighted Avg Shares Outstanding | $87.10M | $87.10M | $87.10M | $85.53M |
| Weighted Avg Shares Outstanding (Diluted) | $96.10M | $87.10M | $87.10M | $85.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan